IMPEL NEUROPHARMA INC — Form D
IMPEL NEUROPHARMA INC of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-01. The offering totals $37.3M, of which $22.3M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2016-12-01
- Form: D
- Accession: 0001168404-16-000044
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $37.3M
- Amount sold: $22.3M
- Remaining: $15.0M
- Investors: 10
- Date of first sale: 2016-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275488
Issuer
- Name: IMPEL NEUROPHARMA INC
- CIK: 0001445499
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 720 BROADWAY AVE., SEATTLE, WA, 98122
- Phone: 206-568-1466
Officers, directors & promoters (25)
| Name | Role | Location |
|---|
| Robert D Mittendorff | Director | Belmont, CA |
| John D Leaman | Executive Officer | Seattle, WA |
| Aaron D Royston | Director | Seattle, WA |
| John D Hoekman | Director | Seattle, WA |
| John D Hoekman | Executive Officer | Seattle, WA |
| Ali D Satvat | Director | Seattle, WA |
| Adrian D Adams | Director | Seattle, WA |
| Adrian D Adams | Executive Officer | Seattle, WA |
| Mahendra D Shah | Director | Seattle, WA |
| Diane D Wilfong | Director | Seattle, WA |
| Tim D Nelson | Director | Seattle, WA |
| Stewart D Parker | Director | Seattle, WA |
| Jon D Congleton | Director | Seattle, WA |
| Jon D Congleton | Executive Officer | Seattle, WA |
| Jim D Young | Director | Seattle, WA |
| Michael D Hite | Director | Seattle, WA |
| Michael P Hite | Director | Seattle, WA |
| Michael P Hite | Executive Officer | Seattle, WA |
| Rodney D Ho | Director | Seattle, WA |
| David D Allison | Director | — |
| Michael P. Hite | Director | Seattle, WA |
| Michael P. Hite | Executive Officer | Seattle, WA |
| Rodney D. Ho | Director | Seattle, WA |
| John D. Hoekman | Director | Seattle, WA |
| John D. Hoekman | Executive Officer | Seattle, WA |
Other filings by this issuer (15)
More